Summary

This document appears to be a study guide for an exam or course, likely in the field of nursing or medicine, based on the topics covered, including pulmonary embolism, acute respiratory failure, and lung cancer. Diagnostic tests, clinical manifestations, and nursing management are also discussed.

Full Transcript

N443: Exam 1 Study Guide Pulmonary Embolism ♡♡♡♡ ​ Pathophysiology o​ Blockage of pulmonary arteries by a thrombus, fat, air, or tumor o​ Impairs gas exchange and can cause hemodynamic instability ​ Clinical Manifestations o​ Dyspnea, chest pain, tachycardia, cough...

N443: Exam 1 Study Guide Pulmonary Embolism ♡♡♡♡ ​ Pathophysiology o​ Blockage of pulmonary arteries by a thrombus, fat, air, or tumor o​ Impairs gas exchange and can cause hemodynamic instability ​ Clinical Manifestations o​ Dyspnea, chest pain, tachycardia, cough o​ Hypoxemia, anxiety, and possible hemoptysis ​ Diagnostic Tests o​ ABG analysis, chest x-ray, ECG o​ D-dimer test o​ Spiral CT scan is the most common test (CT PE) o​ V/Q scan if CT is contraindicated ​ Management o​ Oxygen therapy o​ Anticoagulation (heparin, low-molecular-weight heparin, factor Xa inhibitors) o​ Fibrinolytic agents for massive PE o​ Inferior vena cava (IVC) filter may be needed ​ Nursing Management o​ Assess cardiorespiratory status o​ Administer oxygen and medications o​ Provide emotional support o​ Patient education on long-term anticoagulation therapy Acute Respiratory Failure ♡♡♡♡ ​ Types o​ Hypoxemic Respiratory Failure: Oxygenation failure ▪​ PaO2 ≤ 60 mm Hg on ≥ 60% oxygen o​ Hypercapnic Respiratory Failure: Ventilatory failure ▪​ PaCO2 > 50 mm Hg and pH < 7.35 ​ Causes o​ Respiratory system issues (e.g., pneumonia, ARDS, COPD) o​ Cardiac issues (e.g., pulmonary edema, anatomic shunt) ​ Clinical Manifestations 1 o​ Dyspnea, changes in breathing pattern, use of accessory muscles, and changes in mental status o​ Tachycardia, dysrhythmias, changes in blood pressure o​ Skin may be pale, cool, clammy, or warm and flushed ​ Diagnostic Tests o​ Arterial blood gas o​ Chest x-ray o​ Pulse oximetry ​ Management o​ Oxygen therapy o​ Mobilization of secretions o​ Cough/deep breathe o​ Suctioning o​ Humidification o​ Noninvasive or invasive ventilation o​ Treat underlying cause ​ Nursing Management o​ Assess for airway patency, breathing effort, and overall respiratory status o​ Monitor vital signs, ABGs, and pulse oximetry o​ Provide emotional support o​ Prevent complications Acute Respiratory Distress Syndrome (ARDS) ♡♡♡♡ ​ Pathophysiology o​ Severe form of ARF characterized by damage to the alveolar-capillary membrane o​ Leads to decreased surfactant production, atelectasis, and impaired gas exchange o​ Inflammatory mediators increase alveolar capillary permeability ​ Diagnostic Criteria o​ Timing within one week of a known clinical insult o​ Bilateral opacities on chest x-ray that cannot be attributed to volume overload o​ Oxygenation issues ​ Clinical Manifestations o​ Similar to ARF, but more severe 2 o​ Hypoxemia refractory to oxygen therapy ​ Management o​ Mechanical ventilation with low tidal volume o​ Positive end-expiratory pressure (PEEP) o​ Positioning strategies, like prone positioning o​ Extracorporeal membrane oxygenation (ECMO) ​ Complications o​ Cardiovascular: increased CO, dysrhythmias, hypotension o​ CNS and Psychological: delirium, PTSD o​ GI: Hypermetabolic state, paralytic ileus, GI bleeding o​ Hematologic: anemia, disseminated intravascular coagulation, thrombocytopenia o​ Renal: AKI ​ Nursing Management o​ Similar to ARF, but more intensive monitoring and care o​ Frequent ABG monitoring o​ Analgesia, sedation, and neuromuscular blockade may be needed Lung Cancer ♡♡♡♡ ​ Types o​ Non-small cell lung cancer (NSCLC) most common ​ Etiology o​ Smoking is the most significant risk factor o​ Other risk factors include exposure to secondhand smoke, airborne carcinogens, and chronic lung disease ​ Clinical Manifestations o​ Cough, hemoptysis, dyspnea, chest pain, hoarseness, and fatigue ​ Diagnostic Tests o​ Chest x-ray, CT scan, and MRI o​ Sputum cytology, biopsy o​ Bone scans and scans of the brain, pelvis, and abdomen ​ Staging o​ Stages range from 0 to IV based on tumor size, lymph node involvement, and metastasis ​ Management o​ Surgery (lobectomy, pneumonectomy) o​ Radiation therapy 3 o​ Chemotherapy and immunotherapy o​ Targeted therapy ​ Screening o​ Annual low dose CT for high-risk patients (ages 50 to 80 with history of smoking) ​ Nursing Management o​ Assess understanding of disease, treatment, and prognosis o​ Provide support, education, and symptom management o​ Smoking cessation counseling Acute Kidney Injury (AKI) ♡♡♡♡ ​ Causes o​ Prerenal: Decreased blood flow to the kidneys (e.g., hypovolemia, heart failure) o​ Intrarenal: Direct damage to kidney tissue (e.g., nephrotoxins, ischemia) o​ Postrenal: Obstruction of urine flow (e.g., stones, BPH) ​ RIFLE Classification o​ Risk, Injury, Failure, Loss, End-stage kidney disease o​ Uses serum creatinine and urine output criteria to define the stage of AKI ​ Clinical Manifestations o​ Oliguria or anuria, though nonoliguric AKI is also possible o​ Changes in urine output and serum creatinine o​ Urinalysis may show casts, RBCs, and WBCs ​ Diagnostic Tests o​ History and physical assessment o​ Urinalysis and serum creatinine and BUN o​ Kidney ultrasound o​ Renal scan or CT scan o​ Renal biopsy for intrarenal causes ​ Management o​ Treat underlying cause o​ Fluid restriction o​ Nutritional support o​ Measures to lower potassium levels o​ Calcium supplements or phosphate-binding agents 4 o​ Dialysis or continuous renal replacement therapy o​ Avoid nephrotoxic agents ​ Nursing Management o​ Monitor daily weights, intake/output, and vital signs o​ Assess urine for color, specific gravity, glucose, protein, blood, and sediment o​ Skin and mouth care o​ Monitor for electrolyte imbalances Pyelonephritis ♡♡♡♡ ​ Pathophysiology o​ Infection of the renal parenchyma o​ Usually caused by ascending bacterial infection from the lower urinary tract o​ Risk factors include structural abnormalities, pregnancy, and vesicoureteral reflux ​ Clinical Manifestations o​ Fever/chills, nausea/vomiting, malaise, and flank pain o​ Dysuria, urgency, and frequency ​ Diagnostic Tests o​ Urinalysis o​ Urine culture and sensitivity o​ Imaging studies like ultrasound, CT scan, or MRI ​ Management o​ Antibiotics o​ Adequate fluid intake o​ Symptom management with NSAIDs or antipyretics o​ Possible hospitalization if severe ​ Nursing Management o​ Patient education on antibiotic therapy, fluid intake, and follow-up Urinary Tract Calculi (Kidney Stones) ♡♡♡♡ ​ Pathophysiology o​ Supersaturation of crystal-forming substances in urine o​ Contributing factors: climate, diet, genetics, metabolic, and lifestyle o​ Dehydration and concentrated urine increase risk 5 o​ Urinary pH affects stone formation ​ Clinical Manifestations o​ Severe, colicky pain in flank, back, abdomen, or groin o​ Hematuria and crystalluria o​ Urinary urgency and frequency ​ Diagnostic Tests o​ Noncontrast CT scan or ultrasound o​ Urinalysis o​ 24-hour urine collection for measurement of minerals ​ Management o​ Pain management with opioids or NSAIDs o​ α-Adrenergic blockers (e.g., tamsulosin) to help with stone passage o​ Increase fluid intake o​ Dietary changes and restrictions depending on stone type o​ Endourologic procedures (cystoscopy, lithotripsy) o​ Extracorporeal shock-wave lithotripsy (ESWL) o​ Open surgical stone removal ​ Nursing Management o​ Assess pain, fluid intake, and urinary symptoms o​ Strain all urine to retrieve stones for analysis o​ Patient education on diet, hydration, and medications o​ Encourage ambulation Anemia ♡♡♡♡ ​ General Concepts o​ Reduction in the number of red blood cells (RBCs), hemoglobin, or hematocrit o​ Leads to decreased oxygen carrying capacity ​ Clinical Manifestations o​ Fatigue, pallor, tachycardia, dyspnea, and other signs related to tissue hypoxia ​ Nutritional Support o​ Adequate intake of protein, iron, vitamin B12, folic acid, copper, niacin, and vitamin B5 is necessary for RBC production ​ Iron Deficiency Anemia o​ Caused by blood loss, poor iron intake, or poor absorption o​ Low Hgb, Hct, serum iron, ferritin and high TIBC 6 o​ Treatment with oral or parenteral iron supplements and dietary changes ​ Megaloblastic Anemia o​ Caused by cobalamin (vitamin B12) or folic acid deficiency o​ Macrocytic RBCs, low serum cobalamin or folate levels o​ Treatment with replacement therapy ​ Anemia of Chronic Disease o​ Underproduction of RBCs and shortened RBC survival o​ Normocytic, normochromic, and hypoproliferative ​ Aplastic Anemia o​ Pancytopenia, low levels of all blood cells (RBC, WBC, platelets) o​ Normocytic, normochromic anemia, and low reticulocyte count ​ Anemia due to Acute Blood Loss o​ Results from hemorrhage or trauma o​ Hgb, Hct, and RBC will be decreased o​ Treatment focuses on stopping the bleeding, fluid replacement, and possible blood transfusions ​ Hemolytic Anemia o​ Caused by increased destruction of RBCs o​ Elevated bilirubin levels, jaundice, high reticulocytes, and abnormal blood smear o​ Treatment includes supportive care and addressing the underlying cause ​ Sickle Cell Anemia o​ Genetic disorder caused by a mutation in the beta-globin gene o​ Sickled cells cause vaso-occlusion, pain, and organ damage o​ Treatment focuses on managing pain crises and preventing complications ​ Thalassemia o​ Genetic defect in globin synthesis o​ RBCs are microcytic and hypochromic o​ Treatment includes blood transfusions, iron chelation, and HSCT ​ Polycythemia Vera o​ Excessive production of RBCs o​ Increased blood viscosity and risk for thrombus formation o​ Treatment includes phlebotomy, hydration therapy, and myelosuppressive drugs 7 ​ Nursing Management o​ Assess knowledge of nutrition, safety, and disease o​ Encourage rest, monitor cardiorespiratory response to activity, and aid with ADLs o​ Provide education on diet, medications, and potential complications Human Immunodeficiency Virus (HIV) ♡♡♡♡ ​ Pathophysiology o​ HIV is a retrovirus that causes immunosuppression o​ Targets CD4+ T cells, eventual destruction of CD4+ cells o​ Opportunistic diseases develop ​ Transmission o​ Through infected blood, semen, vaginal secretions, or breast milk ​ Progression o​ Acute infection, followed by a period where the HIV antibody test becomes positive o​ Symptomatic infection develops with declining CD4 counts and increasing viral load o​ AIDS is diagnosed when the CD4 count drops below 200 cells/μL, or if certain opportunistic infections or cancers develop ​ Clinical Manifestations o​ Symptoms such as persistent fever, night sweats, diarrhea, headaches, and severe fatigue may occur as the CD4 count declines o​ Opportunistic infections ​ Diagnosis o​ HIV antibody/antigen tests o​ Confirmation with HIV viral load testing o​ Monitoring with CD4 counts and viral load ​ Treatment o​ Antiretroviral therapy (ART) is used to suppress viral load o​ ART does not cure HIV ​ Prevention o​ Pre-exposure prophylaxis (PrEP) for high-risk individuals o​ Post-exposure prophylaxis (nPEP) within 72 hours of exposure 8 o​ Safer sexual practices and avoiding sharing drug equipment o​ Regular testing ​ Nursing Management o​ Assessment of risk factors o​ Patient education on transmission, treatment, and prevention o​ Emotional support and counseling Disseminated Intravascular Coagulation (DIC) ♡♡♡♡ ​ Pathophysiology o​ Life-threatening condition involving widespread activation of the clotting cascade, leading to both thrombosis and hemorrhage o​ Caused by an underlying disease or condition ​ Risk Factors o​ Cancers, hemolytic processes, obstetric conditions, septicemia, shock, and tissue damage ​ Clinical Manifestations o​ Bleeding, tissue damage, and organ ischemia or infarction ​ Diagnostic Tests o​ Prolonged PT, PTT, aPTT o​ Decreased fibrinogen and platelets o​ Increased D-dimer o​ Presence of schistocytes on peripheral blood smear ​ Management o​ Treat the underlying cause o​ Blood product support (platelets, cryoprecipitate, fresh frozen plasma) o​ Careful monitoring and supportive care ​ Nursing Management o​ Minimize tissue damage o​ Protect patient from bleeding sources o​ Blood products and medications 9